文献速递泌尿生殖神经胸部CTMRUS

成人TSC2/PKD1连续基因缺失综合征影像特征

Imaging features of TSC2/PKD1 contiguous gene deletion syndrome in adults.
PubMed 文献 · Abdom Radiol (NY) · 2026-09-04

多中心回顾性研究纳入9例基因确诊的TSC2/PKD1连续基因缺失综合征成人患者,由两名放射科医师独立评估MRI、CT及超声影像。全部患者表现为双肾增大伴多囊改变,78%合并血管平滑肌脂肪瘤,67%发生终末期肾病,肾外可见脑室管膜下结节、肝囊肿及肝血管平滑肌脂肪瘤等。

要点

  • 多囊肾背景下发现血管平滑肌脂肪瘤应提示TSC2/PKD1连续基因缺失综合征可能
  • Mayo影像分级1E不能直接用于该综合征预后判断,因肾体积含实性血管平滑肌脂肪瘤成分
  • 需注意富脂与乏脂型血管平滑肌脂肪瘤并存,乏脂型病变难以与肾细胞癌鉴别

核心结论

  • 成人TSC2/PKD1连续基因缺失综合征表现为兼具常染色体显性多囊肾病与结节性硬化症特征的独特影像表型
  • 在ADPKD样囊性肾病背景下识别血管平滑肌脂肪瘤应提示连续基因缺失综合征的可能

研究设计与样本

  • 多中心回顾性研究,纳入9例基因确诊TSC2/PKD1连续基因缺失综合征成人患者,平均年龄29±8岁
  • 由两名放射科医师独立评估MRI、CT及超声影像,评估肾长径、总肾体积、身高校正总肾体积、囊肿负荷及肾外表现

关键影像表现/征象

  • 全部患者表现为双肾增大的多囊肾,平均总肾体积2134±904 mL,平均身高校正总肾体积1260±471 mL/m
  • 肾脏囊肿负荷高,每侧肾脏中位囊肿数为45个;8例可分级患者中7例(88%)归入Mayo影像分级1E
  • 血管平滑肌脂肪瘤见于78%病例,同时存在富脂型与乏脂型两种亚型
  • 肾外影像表现包括全部患者可见脑皮质结节和室管膜下结节,肝囊肿56%,肝血管平滑肌脂肪瘤33%,肺淋巴管平滑肌瘤病22%,心脏横纹肌瘤22%

诊断标准与关键数值

  • Mayo影像分级1E:8例可分级患者中7例(88%)归入该级,该分级在ADPKD中已验证但其预后价值不能直接外推至CGS
  • 平均总肾体积2134±904 mL,平均身高校正总肾体积1260±471 mL/m,每侧肾脏中位囊肿数45个
  • 终末期肾病发生率为67%,中位发生年龄25岁

临床应用与阅片要点

  • 在ADPKD样囊性肾病中应主动寻找有无血管平滑肌脂肪瘤,包括乏脂型病变
  • 报告应描述囊肿负荷与实性血管平滑肌脂肪瘤成分,避免单纯以总肾体积套用ADPKD预后模型
  • 乏脂型血管平滑肌脂肪瘤生长时需要与肾细胞癌鉴别,可建议进一步检查或活检

局限性

  • 样本量仅9例,为回顾性多中心研究
  • Mayo影像分级在连续基因缺失综合征中的预后价值未经验证

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To report the first detailed description of the radiological features of tuberous sclerosis complex 2/polycystic kidney disease 1 (TSC2/PKD1) contiguous gene deletion syndrome (CGS), a rare and poorly reported or described syndrome.

METHODS: This multicenter retrospective study included 9 adult patients (6 women, 3 men; mean age, 29±8 years) with genetically confirmed TSC2/PKD1 CGS. Clinical data and imaging studies (MRI, CT, ultrasound) were reviewed independently by two radiologists. Radiological features assessed included kidney length, total kidney volume (TKV), height-adjusted TKV (hTKV), cyst burden, angiomyolipomas (AMLs), and extrarenal manifestations.

RESULTS: All patients presented with enlarged polycystic kidneys (mean TKV: 2134 ± 904 mL; mean hTKV: 1260 ± 471 mL/m) and a high cyst burden (median 45 cysts per kidney); 7 of 8 classifiable patients (88%) were assigned to Mayo imaging class 1E, a classification validated in ADPKD whose prognostic value cannot be directly transposed to CGS, where renal volume also reflects solid angiomyolipomatous tissue. AMLs were observed in 78% of cases, with both fat-rich and fat-poor subtypes. One patient developed a hemorrhagic AML requiring embolization and underwent nephrectomy for a growing fat-poor lesion, ultimately diagnosed as AML. End-stage renal disease occurred in 67% of patients at a median age of 25 years. Extrarenal findings included cerebral cortical tubers and subependymal nodules in all patients, hepatic cysts (56%), hepatic AMLs (33%), pulmonary lymphangioleiomyomatosis (22%), and cardiac rhabdomyomas (22%).

CONCLUSION: Adult patients with TSC2/PKD1 CGS exhibit a distinct imaging phenotype characterized by features of both ADPKD and TSC. The identification of AML in the context of ADPKD-like cystic disease should prompt consideration of CGS. Early diagnosis is crucial for guiding appropriate follow-up, therapeutic interventions, and genetic counseling.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Bitton, Boudhabhay, Dariane, et al. Imaging features of TSC2/PKD1 contiguous gene deletion syndrome in adults. Abdom Radiol (NY). 2026. PMID: 42696112. doi:10.1007/s00261-026-05768-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。